Authors:
Wollinsky, KH
Hulser, PJ
Brinkmeier, H
Aulkemeyer, P
Bossenecker, W
Huber-Hartmann, KH
Rohrbach, P
Schreiber, H
Weber, F
Kron, M
Buchele, G
Mehrkens, HH
Ludolph, AC
Rudel, R
Citation: Kh. Wollinsky et al., CSF filtration is an effective treatment of Guillain-Barre syndrome - A randomized clinical trial, NEUROLOGY, 57(5), 2001, pp. 774-780
Authors:
Brinkmeier, H
Aulkemeyer, P
Wollinsky, KH
Rudel, R
Citation: H. Brinkmeier et al., An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system, NAT MED, 6(7), 2000, pp. 808-811
Authors:
Aulkemeyer, P
Hausner, G
Brinkmeier, H
Weber, F
Wurz, A
Heidenreich, F
Rudel, R
Citation: P. Aulkemeyer et al., The small sodium-channel blocking factor in the cerebrospinal fluid of multiple sclerosis patients is probably an oligopeptide, J NEUR SCI, 172(1), 2000, pp. 49-54
Authors:
Weber, F
Brinkmeier, H
Aulkemeyer, P
Wollinsky, KH
Rudel, R
Citation: F. Weber et al., A small sodium channel blacking factor in the cerebrospinal fluid is preferentially found in Guillain-Barre syndrome: a combined cell physiological and HPLC study, J NEUROL, 246(10), 1999, pp. 955-960